The queries for the articles about mechanism of GLP-1RAs in liver disease and the clinical experiments: ((GLP-1RAs[Title/Abstract]) OR (GLP-1R agonists[Title/Abstract]) OR (GLP-1 receptor agonists[Title/Abstract]) OR (GLP-1 receptor[Title/Abstract])) AND ((liver[Title/Abstract]) OR (hepatic[Title/Abstract]) OR (HCC[Title/Abstract]) OR (fibrosis[Title/Abstract]) OR (cirrhosis[Title/Abstract]) OR (NAFLD[Title/Abstract]) OR (MASLD[Title/Abstract])) AND ((inflammation[Title/Abstract]) OR (immun*[Title/Abstract]) OR (T cell[Title/Abstract]) OR (B cell[Title/Abstract]) OR (NK cell[Title/Abstract]) OR (macrophage[Title/Abstract]))
GLP-1 drugs alter the gut microbiome
So, what is the safety with biologics, methotrexate and GLP-1s
10.1016/j.neubiorev.2003.11.010 39 LautarS
Support strength, stamina, and daily performance with scientifically formulated HK Vitals supplements designed to enhance energy, endurance, and overall vitality
Int J Cardiol 292:218224 Dunning BE, Foley JE, Ahrn B (2005) Alpha cell function in health and disease: influence of glucagon-like peptide-1
